Dark zone lymphoma includes aggressive B-cell lymphomas with shared molecular features. While some respond to escalated ...

B-cell lymphoma is a type of blood cancer that affects the B lymphocytes of the immune system. They usually arise in the lymph nodes or in other lymphoid tissue, such as the spleen, bone marrow ...

Medically reviewed by Gagandeep Brar, MD Skin (cutaneous) lymphomas often manifest as a skin rash. Although usually ...

They are generally classified according to the cancer's growth rate as high grade (fast growing ... of genetic subtypes in diffuse large B-cell lymphoma not otherwise specified (DLBCL-NOS ...

RG-6540 is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Primary Mediastinal B-Cell Lymphoma.

30% had de novo diffuse large B-cell lymphoma, 17% had low-grade follicular lymphoma, 8% had transformed indolent non-Hodgkin lymphoma or grade 3B follicular lymphoma, 6% had high-grade B-cell ...

Patients with relapsed or refractory large B-cell lymphoma who received epcoritamab or glofitamab in real-world settings ...

Dexamethasone sodium phosphate is under clinical development by AVM Biotechnology and currently in Phase II for Unspecified B-Cell Lymphomas.

Bristol Myers Squibb Canada (BMS) is pleased to announce Health Canada's approval of Breyanzi® (lisocabtagene maraleucel), a type of chimeric antigen receptor T cell (CAR T) therapy, for the treatment ...

A new type of cell-based immunotherapy shows promise for B-cell lymphomas ... the CAR-NK cells to lymphoma cells. A total of 10 study participants experienced low-grade cytokine release syndrome ...